California Case Summaries

United States v. Hansen — Ninth Circuit Affirms Frequent Multi-Panel Drug Testing Condition on Supervised Release

Unreported / Non-Citable

Case
United States v. Hansen
Court
Ninth Circuit Court of Appeals
Judge
Christen; Bumatay (Donald Trump, 2019); Sanchez (Joe Biden, 2022)
Date Decided
2026-11-19
Docket No.
25-7829
Status
Unreported
Topics
supervised release, drug testing conditions, plain error review, sentencing explanation, deterrence and rehabilitation

Background

Christopher Alan Hansen appealed from a judgment of the United States District Court for the Central District of California, entered by District Judge Fred W. Slaughter, which continued Hansen's term of supervised release while imposing an additional special condition requiring him to submit to eight drug tests per month.

On appeal, Hansen challenged the testing requirement on both procedural and substantive grounds. Procedurally, he argued that the district court failed to adequately consider statutory sentencing goals, failed to provide an adequate explanation, relied on clearly erroneous facts, and failed to address nonfrivolous arguments. Substantively, Hansen argued the condition was unreasonable and useless because prescribed medications would prevent testing from proving illicit methamphetamine use.

The Court’s Holding

Reviewing the procedural claims for plain error, the Ninth Circuit held that the district court committed no error in explaining or justifying the condition. The record showed the district court recognized that positive methamphetamine screens alone would not prove illicit use due to Hansen's prescription medication, but properly determined that regular multi-panel testing would deter use of other illegal substances and promote rehabilitation.

The panel further held that the district court did not abuse its discretion in imposing the condition over Hansen's substantive unreasonableness objection. The court reasoned that requiring eight tests per month directly advanced deterrence, rehabilitation, and public safety under 18 U.S.C. § 3583(d) by capturing other illicit drug use, even if specific methamphetamine detection was complicated by prescription treatment.

Key Takeaways

  • District courts may impose multi-panel drug testing conditions during supervised release to deter non-prescribed illicit drugs even when a defendant holds a valid prescription for a substance in the same testing class.
  • A sentencing court's explanation for supervised release conditions satisfies procedural requirements so long as the record reflects meaningful consideration of statutory goals and nonfrivolous arguments.
  • Substantive unreasonableness challenges fail where the ordered testing regime reasonably advances deterrence, rehabilitation, and public safety without imposing an arbitrary deprivation of liberty.

Why It Matters

The decision confirms that supervised release conditions need not be narrowly tailored to detect only one specific controlled substance if broad multi-panel testing serves independent deterrent and rehabilitative functions across other drug classes.

It also illustrates the high bar defendants face under plain error review when challenging sentencing explanations where the district court's rationale can be readily discerned from the full hearing record.

Read the full opinion (PDF) · Court docket

Scroll to Top